All Stories

  1. The Matrix Metalloproteinases Panel in Multiple Sclerosis Patients Treated with Natalizumab: A Possible Answer to Natalizumab Non- Responders

    Article • CNS & Neurological Disorders - Drug Targets, August 2018, Bentham Science Publishers

    Adina Hutanu, Dr Smaranda Maria Maier, Bianca Emilia Ciurba, Septimiu Voidazan